NeoGenomics Appoints Marjorie Green to Board of Directors

NeoGenomics has filed a Form 3 (Initial Statement of Beneficial Ownership) announcing the appointment of Marjorie C. Green as a Director of the company, effective June 19, 2025.

Accepted by SEC EDGAR 06/24/2025 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NeoGenomics has filed a Form 3 (Initial Statement of Beneficial Ownership) announcing the appointment of Marjorie C. Green as a Director of the company, effective June 19, 2025. The filing discloses that:

• Green currently owns no securities or derivative securities of NeoGenomics
• She serves as a Director but holds no other positions (such as Officer or 10% Owner)
• The filing was submitted individually, not as part of a group
• The document was signed by Ali Olivo as Attorney-in-Fact on June 24, 2025

This Form 3 filing is a standard regulatory requirement for new company insiders under Section 16(a) of the Securities Exchange Act of 1934, establishing their initial ownership position upon assuming their role.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the new director appointed to NeoGenomics (NEO) board in June 2025?

Marjorie C. Green was appointed as a Director of NeoGenomics (NEO) as reported in the Form 3 filing dated June 28, 2025. The appointment was effective June 19, 2025.

Does Marjorie Green own any shares of NeoGenomics (NEO) upon joining the board?

According to the Form 3 filing, Marjorie Green owns no securities of NeoGenomics (NEO) at the time of her appointment. The filing explicitly states 'No securities are beneficially owned.'

What position does Marjorie Green hold at NeoGenomics (NEO)?

Marjorie Green serves as a Director at NeoGenomics (NEO), as indicated by the 'X' marked in the Director box under Section 4 of the Form 3 filing. She does not hold any other officer positions or have 10% ownership in the company.

When did Marjorie Green join the NeoGenomics (NEO) board of directors?

Marjorie Green joined the NeoGenomics (NEO) board of directors on June 19, 2025, as indicated by the 'Date of Event Requiring Statement' in the Form 3 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Green Marjorie C

(Last) (First) (Middle)

9490 NEOGENOMICS WAY

(Street)

FORT MYERS FL 33912

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/19/2025

3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Ali Olivo, Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.